CORRESP Filing
REVELATION BIOSCIENCES, INC.
Date: Feb. 9, 2026 · CIK: 0001810560 · Accession: 0001193125-26-042685
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293078
Letter
VIA EDGAR AND E-MAIL Mr. Chris Edwards Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7010 Registration Statement on Form S-3 Commission File No. 333-293078
Re: Revelation Biosciences, Inc.
Dear Mr. Edwards: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Revelation Biosciences Inc. (the “Company”) hereby requests that the effectiveness of the Company’s Registration Statement on Form S-3 (File No. 333-293078) be accelerated by the U.S. Securities and Exchange Commission to 4:00 p.m. Eastern Time on Wednesday, February 11, 2026 or as soon thereafter is practicable. The Company hereby authorizes Joseph P. Galda of J.P. Galda & Co. to orally modify or withdraw this request for acceleration. Please contact Mr. Galda at (215) 815-1534 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter.
Very truly yours,
Revelation Biosciences, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Revelation Biosciences, Inc. 4660 La Jolla Village Drive, Suite 100 San Diego, California 92122 February 9, 2026 VIA EDGAR AND E-MAIL Mr. Chris Edwards Office of Life Sciences Division of Corporate Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7010 Re: Revelation Biosciences, Inc. Registration Statement on Form S-3 Commission File No. 333-293078 Dear Mr. Edwards: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Revelation Biosciences Inc. (the “Company”) hereby requests that the effectiveness of the Company’s Registration Statement on Form S-3 (File No. 333-293078) be accelerated by the U.S. Securities and Exchange Commission to 4:00 p.m. Eastern Time on Wednesday, February 11, 2026 or as soon thereafter is practicable. The Company hereby authorizes Joseph P. Galda of J.P. Galda & Co. to orally modify or withdraw this request for acceleration. Please contact Mr. Galda at (215) 815-1534 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Thank you for your courtesy and cooperation in this matter. Very truly yours, Revelation Biosciences, Inc. /s/ Chester S. Zygmont, III Chief Financial Officer